Evidence map›Paper›PMID 16374520›Full record

ArticleThe Journal of clinical investigation2006

Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth.

Xiaocheng Dong, Sunmin Park, Xueying Lin, Kyle Copps, Xianjin Yi, Morris F White

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 227 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growth.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  5. Review
  6. Deregulated miR-487b-3p in Patients with Non-Alcoholic Fatty Liver Disease and Its Regulatory Effect on Insulin Resistance.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026
    Article
  7. Review
  8. Article
  9. Gut microbes · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Flavonoid-Rich Extracts from Chuju (Foods (Basel, Switzerland) · 2025
    Article
  15. Review
  16. Review
  17. Liver as a nexus of daily metabolic cross talk.International review of cell and molecular biology · 2025
    Review
  18. Comparative analysis of two independent Myh6-Cre transgenic mouse lines.Journal of molecular and cellular cardiology plus · 2024
    Article
  19. Article
  20. 5'-Cytimidine Monophosphate Ameliorates HAntioxidants (Basel, Switzerland) · 2024
    Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Xiaocheng DongHoward Hughes Medical Institute, Division of Endocrinology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA.
Sunmin Park
Xueying Lin
Kyle Copps
Xianjin Yi
Morris F White
Howard Hughes Medical Institute · USHarvard University · USHarvard University Press · US

Funding

Regulating IRS-proteins by Ser/Thr PhosphorylationR01DK038712 · NIDDK · JOSLIN DIABETES CENTER · PI WHITE, MORRIS F. · 1992 to 2014
$5.0M
STRUCTURE AND FUNCTION OF THE IRS SIGNALING SYSTEMR01DK043808 · NIDDK · JOSLIN DIABETES CENTER · PI WHITE, MORRIS F. · 1991 to 2004
$1.7M
NIDDK NIH HHS DK43808NIDDK NIH HHS DK55236NIDDK NIH HHS R01 DK038712NIDDK NIH HHS R01 DK043808
6 · The paper itself

Abstract

Insulin receptor substrates, including Irs1 and Irs2, integrate insulin and IGF receptor signals with heterologous pathways to coordinate growth and metabolism. Since Irs2 is thought to be especially important in hepatic nutrient homeostasis, we deleted Irs2 [corrected] from hepatocytes of WT mice (called LKO) or genetically insulin-resistant Irs1-/- mice (called LKO::Irs1-/-). Viable LKO::Irs1-/- mice were 70% smaller than WT or LKO mice, and 40% smaller than Irs1-/- mice. Hepatic insulin receptors were functional in all the mice, but insulin signaling via the Akt-FoxO1 pathway was reduced in Irs1-/- and LKO liver, and undetected in LKO::Irs1-/- liver; however, Gsk3beta phosphorylation (Ser9) and hepatic glycogen stores were nearly normal in all of the mice. LKO and Irs1-/- mice developed insulin resistance and glucose intolerance that never progressed to diabetes, whereas LKO::Irs1-/- mice developed hyperglycemia and hyperinsulinemia immediately after birth. Regardless, few hepatic genes changed expression significantly in Irs1-/- or LKO mice, whereas hundreds of genes changed in LKO::Irs1-/- mice--including elevated levels of Pck1, G6pc, Ppargc1, Pparg, and Igfbp1. Thus, signals delivered by Irs1 or Irs2 regulate hepatic gene expression that coordinates glucose homeostasis and systemic growth.

Indexed as

AnimalsApoptosisBody WeightBone DensityGlucoseHomeostasisInsulin Receptor Substrate ProteinsIntracellular Signaling Peptides and ProteinsLiverMiceMice, KnockoutOrgan SizePancreasPhosphoproteinsReceptor, InsulinSignal TransductionGlucoseInsulin Receptor Substrate ProteinsIntracellular Signaling Peptides and ProteinsIrs1 protein, mouseIrs2 protein, mousePhosphoproteinsReceptor, Insulin

Identifiers

PMID16374520
PMCPMC1319221
OpenAlexW2013655374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.